| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Volker Nickeleit | |
| Michael J Mihatsch | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 2232-2239 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Kidney transplants, antibodies and rejection: is C4d a magic marker? | |
| P478 | volume | 18 |
| Q51681831 | Acquired Downregulation of Donor-Specific Antibody Production After ABO-Incompatible Kidney Transplantation. |
| Q84702184 | Activation of the complement system in human nonalcoholic fatty liver disease |
| Q26766411 | Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen |
| Q61945632 | Analysis of Specificity of Anti–Human Leukocyte Antigen Antibodies in Kidney Recipients in Reference to Clinical Outcome |
| Q64226620 | Angiotensin II Type 1 Receptor Antibodies Trigger Inflammation in Renal Transplantation |
| Q82213207 | Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients |
| Q37904197 | Antibody-mediated allograft rejection: the emerging role of endothelial cell signalling and transcription factors. |
| Q93562475 | Authors' reply |
| Q90696052 | Automated detection algorithm for C4d immunostaining showed comparable diagnostic performance to pathologists in renal allograft biopsy |
| Q46966010 | C4d complement split product in diagnosis of immunological activity of chronic allograft nephropathy. |
| Q46310957 | C4d deposition is associated with chronic allograft nephropathy in rats and could be influenced by immunosuppressants |
| Q53142399 | C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis? |
| Q52934767 | C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. |
| Q41944673 | C4d staining in allograft biopsies |
| Q51770229 | Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. |
| Q45681850 | Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss |
| Q46493708 | Complement split product C4d deposition in placenta in systemic lupus erythematosus and pregnancy-induced hypertension. |
| Q86601056 | Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome? |
| Q37882017 | Current problems of chronic active antibody-mediated rejection |
| Q50548088 | DRβ1*1501, DQβ1*0602 donor allelic haplotype and humoral antibody episodes of acute renal allograft rejection. |
| Q40571069 | Evaluation of Renal Allograft Biopsies for Graft Dysfunction and Relevance of C4d Staining in Antibody Mediated Rejection |
| Q53641782 | Focal peritubular capillary C4d deposition in acute rejection. |
| Q83192295 | Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form |
| Q33885388 | Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes. |
| Q49297064 | Impact of complement component 3/4/5 single nucleotide polymorphisms on renal transplant recipients with antibody-mediated rejection |
| Q58378349 | Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial |
| Q27006030 | Late and chronic antibody-mediated rejection: main barrier to long term graft survival |
| Q39045577 | Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best? |
| Q47347260 | National conference to assess antibody-mediated rejection in solid organ transplantation |
| Q35574072 | Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching |
| Q36529421 | Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable? |
| Q38005448 | Phenotypes of antibody-mediated rejection in organ transplants |
| Q35469913 | Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts. |
| Q42439336 | Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study |
| Q35338994 | Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia |
| Q52938088 | Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. |
| Q34534855 | Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection |
| Q39712114 | Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes |
| Q30544649 | Pros and cons for C4d as a biomarker |
| Q46857776 | Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system |
| Q27490515 | Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage |
| Q30317554 | Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes |
| Q50507367 | Significance of C4d deposition in antibody-mediated rejection. |
| Q36682686 | The classification and treatment of antibody-mediated renal allograft injury: where do we stand? |
| Q44613788 | The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft |
| Q46105901 | The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection |
| Q27021227 | The importance of C4d in biopsies of kidney transplant recipients |
| Q54116671 | The prognostic values of caveolin-1 immunoreactivity in peritubular capillaries in patients with kidney transplantation. |
| Q79882539 | The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection |
| Q80252616 | Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil |
| Q79979170 | [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions] |
Search more.